Research
Two research and development (R&D) awards have been earmarked by the Department of Homeland Security (DHS) for the newly launched Secure and Resilient Mobile Network Infrastructure (SRMNI) project.
The Agency's Science and Technology Directorate (S&T) and Cybersecurity and Infrastructure... Read More »
Dr. Rick Bright has been appointed the Rockefeller Foundation as senior vice president of Pandemic Prevention and Response, with responsibilities including leading pandemic prevention institute development.
“We are thrilled to have someone of Rick’s caliber join The Rockefeller... Read More »
According to a new report from the U.S. Centers for Disease Control and Prevention (CDC) and the University of Utah, the costs of antibiotic resistance among diseases are growing, leading to billions of dollars in health care costs and increasing rates of infections.
According to “National... Read More »
Nuclear Threat Initiative (NTI) officials indicated its recent Global Biosecurity Dialogue resulted in participants pledging to take 12 specific actions to advance global biosecurity along with eight jointly developed priority areas.
More than 170 government officials, health and biosecurity... Read More »
The preliminary results of a Phase 2a randomized, double-blind trial of the Merck and Ridgeback Biotherapeutics-created oral antiviral for the treatment of COVID-19, molnupiravir, have shown the ability to quickly decrease the infectious virus among patients.
While full results are pending, this... Read More »
Through a deal between the World Health Organization and others with GSK, a rotavirus vaccine will be available to more children living in low-income nations facing humanitarian crises.
The agreement makes use of the multi-partner Humanitarian Mechanism, launched in 2017, where manufacturers... Read More »
Lockheed Martin is touting the successful testing of its next-generation Extended-Range Guided Multiple Launch Rocket System (ER GMLRS) munition via an 80-kilometer flight demonstration at White Sands Missile Range.
“Our new Extended-Range GMLRS significantly increases the range of the... Read More »
New research from the Washington University School of Medicine in St. Louis seemingly confirms scientists' and health experts' worst fear that all three of the prominent, fast-spreading variants of COVID-19 can resist vaccines and antibodies currently effective against their forebear.
Published... Read More »
Under a new agreement, Novartis will manufacture the mRNA and bulk drug product for CureVac’s CVnCoV vaccine candidate for COVID-19, with a goal of up to 50 million doses by the end of 2021.
“I am very pleased that with Novartis, we have found another highly experienced partner to support... Read More »
Research from Battelle shows that wastewater analysis can pinpoint neighborhoods that are hotspots for viral outbreaks of COVID-19.
A preliminary report was preprinted on Feb. 20 in the MedRxIv found that by testing wastewater for the presence of SARS-COV-2 and other pathogens, they were able... Read More »
In a new study published on bioRxiv, Soligenix, Inc. reported that its CiVax COVID-19 vaccine demonstrated rapid, broad-spectrum, neutralizing antibody and immunity onset in preclinical studies.
The head stable vaccine used full-length Spike protein antigens to do its work, and at least in... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Hologic, Inc. are working together to develop the Panther Fusion SARS-CoV-2/Flu/RSV assay, intended to be able to simultaneously detect and differentiate a variety of viruses from a single sample.
While SARS-CoV-2 is a major... Read More »
A Study of Terrorism and Responses to Terrorism (START) report examining extremism has determined QAnon escalated from an obscure fringe group to a mainstream movement, but few have committed crimes.
START researchers at the University of Maryland compiled QAnon supporter data regarding those... Read More »
A team, including GE Research, the Broad Institute, DNA Script, MEDInstill, Molecular Assemblies, and the University of Washington, has been awarded a five-year, up to $41 million contract from the Defense Advanced Research Projects Agency (DARPA) to create a new, quicker vaccine production... Read More »
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) awarded up to $18 million to GSK Biologicals and its affiliate GSK Vaccines Institute for Global Health (GVGH) to develop new vaccines for two different illnesses.
One is a vaccine for Group A streptococcus... Read More »
The National Institutes of Health (NIH) has earmarked funding totaling nearly $33 million over four years for five University of California San Diego Rapid Acceleration of Diagnostics (RADx) projects.
The RADx initiative seeks to expedite the development, commercialization, and implementation of... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) recently partnered with LightDeck Diagnostics to create a six-minute SARS-CoV-2 antigen test usable without the need for a full diagnostic laboratory.
This point of care test could be used for on-site screening of suspected... Read More »
Department of Homeland Security (DHS) Science and Technology Directorate (S&T) officials are espousing the benefits of resources designed to address GPS spoofing activity.
The Positioning, Navigation and Timing (PNT) Integrity Library and Epsilon Algorithm Suite seeks to protect against Global... Read More »
The United States will now benefit from the rollout of a third COVID-19 vaccine, following last week’s emergency use authorization (EUA) of the Janssen vaccine by the U.S. Food and Drug Administration (FDA).
That decision came in the wake of recommendations from an advisory panel known as the... Read More »
A new report from Johns Hopkins Center for Health Security found that emergency departments in New York City hospitals were overwhelmed and struggled to maintain conventional standards of care during the COVID-19 pandemic.
The report, “Crisis Standards of Care: Lessons from New York City... Read More »
Regeneron Pharmaceuticals is making changes to the Phase 3 trial of its Regen-COV treatment for outpatients with COVID-19.
The changes come at the recommendation of the Independent Data Monitoring Committee (IDMC), which said to no longer use a placebo group in the trial. IDMC found clear... Read More »
Pfizer Inc. and BioNTech announced the beginning of an evaluation into the safety and immunogenicity of a third dose of their COVID-19 vaccine last week to study the effects of a booster vaccine against emerging SARS-CoV-2 variants.
This will be offered to up to 144 participants from the phase... Read More »
According to a new study from the National Cancer Institute (NCI), at least a few months of protection may be granted against reinfection to those with SARS-CoV-2.
As part of the National Institutes of Health, NCI worked with healthcare data analytics companies HealthVerity and Aetion, Inc. and... Read More »
A Phase 1B clinical trial of Lassa fever vaccine INO-4500, developed by INOVIO, began dosing its first patient this week in Ghana.
The vaccine is a first on several fronts: the first candidate for Lassa fever to begin human trials and the first to have trials conducted in West Africa, where the... Read More »
A pair of monoclonal antibodies (mAbs) developed by Regeneron have shown promising signs against the coronavirus that causes Middle East respiratory syndrome (MERS) in a phase one clinical trial that marked the first such test conducted on people.
In all, the National Institute of Allergy and... Read More »
Specialty vaccine company Valneva has initiated a Phase 3 study for its single-shot chikungunya vaccine candidate, VLA1553.
VLA1553 is the only chikungunya vaccine candidate in Phase 3 clinical trials. Chikungunya is a mosquito-borne viral disease caused by the chikungunya virus (CHIKV).... Read More »
Department of Homeland Security (DHS) Science and Technology Directorate (S&T) personnel said the agency is aiding the scientific community and government decision-makers in proactive African Swine Fever approaches.
“Just because a disease isn’t currently present in the United States,... Read More »
In an effort to meet global supply demands, Sanofi has agreed to support the manufacturing of a COVID-19 vaccine made by Janssen Pharmaceutical NV and Janssen Pharmaceuticals, Inc., both of which are part of Johnson & Johnson.
The Janssen candidate has been submitted to the U.S. Food and Drug... Read More »
Lauretta AI, LLC, a start-up based in Arlington, Mass., has secured a Department of Homeland Security (DHS) phase one funding award of $199,950 to aid the development of self-screening Transportation Security Administration (TSA) checkpoints.
The initiative is supported through the DHS's Science... Read More »
Following positive results from preclinical testing at the University of Alabama at Birmingham last year, the Altimmune Inc. COVID-19 vaccine candidate AdCOVID is set to start a phase one clinical trial this week.
Efforts will begin with patient enrollment, now that the U.S. Food and Drug... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Luminex Corporation announced a collaboration on advanced development support of a single test to rapidly detect and differentiate between COVID-19, influenza, and respiratory syncytial virus (RSV).
Prevalent pathogens all,... Read More »
Lawrence Livermore National Laboratory (LLNL) researchers are working to determine if, after a terrorist bombing, the bomb maker can be identified by skin proteins left on bomb components.
As a means of conducting the research, personnel from LLNL's Weapons Complex Integration (WCI) and Global... Read More »
In tests conducted by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), a new screening technology from Smiths Detection broke new ground in efforts to find and contain COVID-19: the capability to detect the virus SARS-CoV-2 in the air.
The BioFlesh Biological... Read More »
Building off a 2020 research and development agreement for coronavirus therapies, GlaxoSmithKline plc (GSK) and Vir Biotechnology, Inc. announced a binding agreement this week to expand that collaboration into new therapies for flu and other respiratory viruses.
The pair will work together on... Read More »
The U.S. Department of Defense awarded a $1.4 million grant to scientists at West Virginia University (WVU) to develop therapeutics to treat infections prone to antibiotic resistance.
Mariette Barbier of the WVU School of Medicine will lead the research effort. Barbier and her team will present... Read More »
